Trial Profile
A bioequivalence study of tadalafil oral film.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2010
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary) ; Type 5 cyclic nucleotide phosphodiesterase inhibitors
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors IntelGenx Corp.
- 02 Sep 2010 Results reported in an IntelGenx media release.
- 02 Sep 2010 New trial record